Agotin

Agomelatine is a novel atypical antidepressant. It is indicated for the treatment of major depressive episodes in adults. It uniquely resynchronizes circadian rhythms to improve sleep quality without sedation, while offering low rates of sexual dysfunction, no discontinuation syndrome, and weight neutrality.

Additionally, it enhances mood, has good tolerability, low discontinuation symptoms, and does not cause significant daytime sedation.

Features